Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia

Hematol Oncol. 2017 Dec;35(4):925-928. doi: 10.1002/hon.2343. Epub 2016 Sep 19.

Authors

Andrea Visentin^{1

2}, Carmela Gurrieri^{1

2}, Silvia Imbergamo¹, Federica Lessi¹, Speranza Antonia Di Maggio¹, Federica Frezzato^{1

2}, Fausto Adami¹, Renato Zambello^{1

2}, Francesco Piazza^{1

2}, Gianpietro Semenzato^{1

2}, Livio Trentin^{1

2}

Affiliations

¹ Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
² Centro di Eccellenza per la Ricerca Biomedica Avanzata, Venetian Institute of Molecular Medicine, Padua, Italy.

PMID: 27641225
DOI: 10.1002/hon.2343

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell* / mortality
Male
Middle Aged
Mycoses* / chemically induced
Mycoses* / drug therapy
Mycoses* / mortality
Retrospective Studies
Risk Factors